Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Psychiatrische Praxis|December 1, 2004
[Influences of second generation antipsychotics on the course of schizophrenia]Thomas MesserCurrent Medical Research and Opinion|March 2, 2021
Review and meta-analysis of add-on tranylcypromine with antipsychotic drugs for the treatment of schizophrenia with predominant negative symptoms: a restoration of evidenceSven Ulrich, Thomas MesserPharmacopsychiatry|December 7, 2018
The Efficacy of Tiapride and Carbamazepine Combination Therapy in Reducing Alcohol Withdrawal Symptoms: A Systematic Review and Meta-AnalysisSahar Latifi, Thomas MesserMMW Fortschritte Der Medizin|January 29, 2010
[The importance of therapeutic drug monitoring for psychotropic drugs]Thomas Messer, Max SchmaussPsychiatrische Praxis|December 13, 2006
[Augmentation strategies for therapy resistant depression - a review]Max Schmauss, Thomas MesserDrugs in R&D|February 6, 2019
Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of ChangeBruno Pacciardi, Alfredo Calcedo, Thomas MesserPsychiatrische Praxis|December 1, 2004
[Rehospitalization rates of newly diagnosed schizophrenic patients on atypical neuroleptic medication]Oliver Strasser, Max Schmauss, Thomas MesserCNS Drugs|January 18, 2005
Efficacy and tolerability of reboxetine in depressive patients treated in routine clinical practiceThomas Messer, Max Schmauss, Judith Lambert-BaumannPsychiatrische Praxis|December 1, 2004
[Management of the atypical antipsychotic olanzapine in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German State hospital]Rita Lutz, Oliver Köhnlein, Max Schmauss, et al.Psychiatrische Praxis|December 1, 2004
[Determining serum concentrations of the modern antipsychotic quetiapin: clinical relevance in therapeutic drug monitoring]Oliver Köhnlein, Rita Lutz, Max Schmauss, et al.Pageof 6